Navigation Links
Toxin Identified For Alzheimer’s Diseas

Researchers from University of New South Wales have identified a toxin that plays// an important role in the progress of the disease of Alzheimer’s in the elderly population.

Researchers had found that there is existence of quinolinic acid neurotoxicity in the brains of patients with Dementia and Alzheimer’s disease. This acid kills the nerve cells of the brain that leads to brain dysfunction and death.

The research paper, which is, published in the current issue of international journal Neuropathology and Applied Neurobiology, says that activation of this toxin pathways are also seen in the cases of Huntington's disease, stroke, and schizophrenia. Quinolinic acid is a part of the biochemical pathway also known as kynurenine pathway.

Researchers feel that there are several drugs, which are currently being tested in the laboratories, which can block these neural pathways. The researchers however maintain that quinolinic acid is not the cause of the disease. It only increases the rate of progression of the disease.

Currently Alzheimer’s disease affects millions of the people above the age of 50 years across the globe and treatment for them is only minimally effective. The new research findings will be able to bring treatment that will be successful in keeping the progress of the disease in hold, and in turn will be able to help the numerous people in improving their quality of life.

Source: EurekAlert

Medindia on Alzheimer’s’ Disease: Further information

Alzheimer’s’ Disease: Alzheimer’s disease affects the brain cells and slowly destroys them. The main symptoms of the disease are decreasing memory, ability to reason, creative abilities and learning powers.

Dementia: Dementia is a condition where the person is affected by impaired intellectual capability. Some signs of dementia are short-term memory loss, inability to do concrete or abstract reasoning, difficulty in concentration, inappropriate behavior in social situations etc. this is not a normal degeneration of cells due to age but an acquired condition.

For more information read: http://www.medindia.net/patients
/patientinfo/
alzheimers_about.htm

'"/>




Related medicine news :


1. Toxins linked with pregnancy loss
2. Toxin connected to Flesh-eating Pneumonia in Kids
3. Vegetables decrease Tobacco Toxins
4. Toxin injections support stroke associated spasticity
5. Indians Stay Away from Coke, Pepsi After Toxin Scare
6. Toxin from the sea to relieve pain
7. UN Fears Melting Of Ice Would Concentrate Toxins in the Chinese Water Supply
8. Gold Nanoparticles Are Good Detectors Biological Toxins
9. Appearance Of Facial Scars Improved By Botulinum Toxin
10. "Beach to Bedside" Study Focuses on Effects of Inhaled Toxins
11. Environmental Toxin Causes Heritable Adult-Onset Diseases
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... 25, 2017 , ... Somnoware, a leading provider of digital ... module. Using this new feature, sleep physicians can now predict the likelihood of ... airway pressure (CPAP), oral, or other forms of sleep apnea therapy. The Somnoware ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place in ... a special report in the May issue of Consumer Reports focused on heart health. ... for results achieved during and after coronary bypass and aortic valve replacement procedures. ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... instrument solutions, announces the continuation of its strategic partnership with and platinum sponsorship ... developing nations in the safe and effective management of complex spine deformity cases, ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s ... bundles, which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project was honored with the ... the American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I ... improve the lives of the poor and underserved in other parts of the world,” ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... product development program, based on its proprietary self-delivering ... Dermatology (SID) 76 th Annual Meeting.  The ... sciences relevant to skin health and disease through ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market is ... Low drug registration cost in Latin American countries and continuous ...
Breaking Medicine Technology: